CNS-Diagnostics: Chimera Biotec Starts Study on Novel Biomarker Detection for Alzheimer's Disease
European Commission supports study including 11 centres from 6 European countries
Abnormalities in the processing of the beta amyloid protein are an important characteristic of Alzheimer's disease. Moreover, recent studies have shown that beta amyloid precursor oligomers play an important role in the early stage of Alzheimer's disease.
"To describe and characterize these oligomers will be one of the most important advancements in the understanding of Alzheimer's disease in the next years" summarizes Jan Detmers, Chimera Biotec´s Business Development Director. Currently, many companies develop drugs that influence the processing of the beta amyloid peptide and its precursors. In this study, it will be investigated whether the oligomers can be used as a diagnostic marker of Alzheimer's disease and whether it can be used to measure the effect of drug treatments.
Most read news
Topics
Organizations
Other news from the department research and development
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.